Tech Company Financing Transactions
Bioliberty Funding Round
Bioliberty secured a $2.7 million venture capital round on 4/4/2023. Backers included Archangels, Eos Advisory and Hanna Capital.
Transaction Overview
Company Name
Announced On
4/4/2023
Transaction Type
Venture Equity
Amount
$2,745,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the capital to complete development of the trial product and finalize the development of its platform, as well as to fund the business through obtaining FDA approval and early commercial engagement in the US with rehabilitation clinics.
Company Information
Company Status
Private & Independent
Industry
Robotics
Mailing Address
Higgs Centre For Innovation Royal Observatory Edinburgh Blac
Edinburgh, Scotland, EH9 3HJ
UK
Edinburgh, Scotland, EH9 3HJ
UK
Phone
Undisclosed
Website
Email Address
Overview
Bioliberty's aim is to empower every human to live a longer independent life by providing assistive robotics and rehabilitative technologies. Four young engineers came together during a global pandemic to empower people living in social isolation. Witnessing the struggles of living with reduced mobility inspired their ideas. Their passion and focus was to enable people to live their lives independently.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rowan Armstrong
Browse more venture capital transactions:
Prev: 4/4/2023: Megaton Finance venture capital transaction
Next: 4/4/2023: Kashet venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs